This meeting was held on November 2, 2017 and addressed implementation of the National Biodefense Strategy and its implications for the Office of Management and Budget, congressional authorization and appropriation, leadership, coordination, collaboration, and innovation.
More information about this meeting, including a full agenda, is available <a href='https://biodefensecommission.org/events/national-biodefense-strategy-implementation-and-implications/'>here.</a>

This meeting was held on November 2, 2017 and addressed implementation of the National Biodefense Strategy and its implications for the Office of Management and Budget, congressional authorization and appropriation, leadership, coordination, collaboration, and innovation. More information about this meeting, including a full agenda, is available here.

This meeting was held on November 2, 2017 and addressed implementation of the National Biodefense Strategy and its implications for the Office of Management and Budget, congressional authorization and appropriation, leadership, coordination, collaboration, and innovation.
More information about this meeting, including a full agenda, is available <a href="https://biodefensecommission.org/events/national-biodefense-strategy-implementation-and-implications/" rel="noopener noreferrer">here.</a>

National Biodefense Strategy: Implementation and Implications

The Bipartisan Commission on Biodefense is a privately funded entity established in 2014 to provide for a comprehensive assessment of the state of U.S. biodefense efforts and to issue recommendations that will foster change.

From 2014-2015, the Commission convened four public meetings in Washington, DC on biological threat awareness, prevention and protection, surveillance and detection, and response and recovery. Current and former Members of Congress, former Administration officials, state and local representatives, thought leaders, and other experts provided their perspectives on current biodefense efforts, including strengths, weaknesses, and opportunities. While much good work has been achieved toward biodefense, these meetings have revealed systemic challenges in the enterprise designed to protect Americans from biological events.

The Commission continues to advocate for uptake of these recommendations at the highest levels of American government, through additional meetings, reports, and other activities, and is the only such body of bipartisan, former high-level policymakers to do so.

Science

Education

Government

Life Sciences

The Bipartisan Commission on Biodefense is a privately funded entity established in 2014 to provide for a comprehensive assessment of the state of U.S. biodefense efforts and to issue recommendations that will foster change. From 2014-2015, the Commission convened four public meetings in Washington, DC on biological threat awareness, prevention and protection, surveillance and detection, and response and recovery. Current and former Members of Congress, former Administration officials, state and local representatives, thought leaders, and other experts provided their perspectives on current biodefense efforts, including strengths, weaknesses, and opportunities. While much good work has been achieved toward biodefense, these meetings have revealed systemic challenges in the enterprise designed to protect Americans from biological events. The Commission continues to advocate for uptake of these recommendations at the highest levels of American government, through additional meetings, reports, and other activities, and is the only such body of bipartisan, former high-level policymakers to do so.

Share National Biodefense Strategy: Implementation and Implications

Sign up to save your podcasts

National Biodefense Strategy: Implementation and Implications

National Biodefense Strategy: Implementation and Implications